TearLab Corp (TEAR):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:TearLab Corp (TEAR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7031
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TearLab Corp (TearLab) is an ophthalmic device company. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. The company conducts it research and development activities through its wholly-owned subsidiary, TearLab Research, Inc. The company sells its products directly in the US, Canada and the UK and through distributors in Europe, South America and Asia. TearLab is headquartered in San Diego, California, the US.

TearLab Corp (TEAR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TearLab Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TearLab Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TearLab Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TearLab Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
TearLab Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TearLab Corp, Medical Equipment, Deal Details 10
Asset Purchase 10
TearLab Completes Acquisition Of Assets Of OcuHub Business Unit From AOAExcel For US$1.4 Million 10
Equity Offering 11
TearLab to Raise USD3 Million in Private Placement of Securities 11
TearLab Files Registration Statement for Public Offering of Units of up to USD15 Million 12
TearLab Files Registration Statement for Public Offering of Shares and Warrants 13
TearLab Raises USD17.3 Million in Public Offering of Shares and Warrants 14
TearLab Withdraws Public Offering of Shares for up to USD15 Million 15
TearLab Completes Public Offering Of Shares For US$40.4 Million 17
TearLab Completes Private Placement Of Shares For US$8 Million 18
TearLab Completes Public Offering Of Common Stock For US$12.4 Million 19
TearLab Completes Private Placement Of Shares For US$2.56 Million Upon Exercise Of Warrants 21
TearLab Corp – Key Competitors 22
TearLab Corp – Key Employees 23
TearLab Corp – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 09, 2018: Tearlab reports second quarter and first half 2018 financial results 25
May 10, 2018: TearLab Announces First Quarter 2018 Financial Results 26
Mar 02, 2018: TearLab Reports Fourth Quarter and Full Year 2017 Financial Results 27
Nov 13, 2017: TearLab Reports Third Quarter and September Year-To-Date 2017 Financial Results 28
Aug 14, 2017: TearLab Reports Second Quarter and First Half 2017 Financial Results 29
May 15, 2017: TearLab Corporation Reports First Quarter 2017 Financial Results 30
Mar 09, 2017: TearLab Corporation Reports Fourth Quarter and Year End 2016 31
Legal and Regulatory 32
Mar 16, 2018: TearLab Announces Voluntary Delisting From Toronto Stock Exchange 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
TearLab Corp, Medical Equipment, Key Facts, 2017 2
TearLab Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
TearLab Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TearLab Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TearLab Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TearLab Corp, Deals By Market, 2012 to YTD 2018 8
TearLab Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TearLab Completes Acquisition Of Assets Of OcuHub Business Unit From AOAExcel For US$1.4 Million 10
TearLab to Raise USD3 Million in Private Placement of Securities 11
TearLab Files Registration Statement for Public Offering of Units of up to USD15 Million 12
TearLab Files Registration Statement for Public Offering of Shares and Warrants 13
TearLab Raises USD17.3 Million in Public Offering of Shares and Warrants 14
TearLab Withdraws Public Offering of Shares for up to USD15 Million 15
TearLab Completes Public Offering Of Shares For US$40.4 Million 17
TearLab Completes Private Placement Of Shares For US$8 Million 18
TearLab Completes Public Offering Of Common Stock For US$12.4 Million 19
TearLab Completes Private Placement Of Shares For US$2.56 Million Upon Exercise Of Warrants 21
TearLab Corp, Key Competitors 22
TearLab Corp, Key Employees 23
TearLab Corp, Subsidiaries 24

List of Figures
TearLab Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
TearLab Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
TearLab Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
TearLab Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
TearLab Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TearLab Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
TearLab Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TearLab Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[TearLab Corp (TEAR):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nipro Corp (8086):医療機器:M&Aディール及び事業提携情報
    Summary Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary …
  • BASF Corp:企業のM&A・事業提携・投資動向
    BASF Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BASF Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Holland Board of Public Works:企業の戦略的SWOT分析
    Holland Board of Public Works - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • TOT Public Company Limited:企業の戦略的SWOT分析
    TOT Public Company Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Siem Offshore Inc (SIOFF):石油・ガス:M&Aディール及び事業提携情報
    Summary Siem Offshore Inc (Siem Offshore), a subsidiary of Siem Industries Inc is a marine service provider that owns and operates modern offshore support vessels for the offshore oil and gas industries. The company offers shipbuilding, ordering and delivery of new vessels, acquisition of modern sec …
  • Dominion Resources Inc:発電所・企業SWOT分析
    Dominion Resources Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Peabody Energy Corporation:企業のM&A・事業提携・投資動向
    Peabody Energy Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Peabody Energy Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Hammond Power Solutions Inc (HPS.A):企業の財務・戦略的SWOT分析
    Hammond Power Solutions Inc (HPS.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • American States Water Company (AWR):企業の財務・戦略的SWOT分析
    Summary American States Water Company (AWR) is a utility service provider that offers water, wastewater and electric services. The utility provides operation, construction management and maintenance services for water and wastewater systems located on military bases across the US. It offers water se …
  • Tower One Wireless Corp (TO):製薬・医療:M&Aディール及び事業提携情報
    Summary Tower One Wireless Corp (Tower One), formerly Pacific Therapeutics Ltd, is a telecom infrastructure company that owns and operates cellular network infrastructure sites. The company’s services include tower construction, site acquisition and zoning, staffing, and RF tech and electrical. Its …
  • Poupart Limited:企業の戦略・SWOT・財務情報
    Poupart Limited - Strategy, SWOT and Corporate Finance Report Summary Poupart Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Patterson-UTI Energy, Inc.:企業の戦略・SWOT・財務情報
    Patterson-UTI Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Patterson-UTI Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mazagon Dock Shipbuilders Ltd:戦略・SWOT・企業財務分析
    Mazagon Dock Shipbuilders Ltd - Strategy, SWOT and Corporate Finance Report Summary Mazagon Dock Shipbuilders Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Bessemer Venture Partners:企業のM&A・事業提携・投資動向
    Bessemer Venture Partners - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bessemer Venture Partners Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Stereotaxis Inc (STXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Stereotaxis Inc (Stereotaxis) designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch solution is an advanced remote robotic navigation system for use in interventional lab for the treatm …
  • ALS Limited (ALQ)-石油・ガス分野:企業M&A・提携分析
    Summary ALS Limited (ALS), formerly, Campbell Brothers Limited is a diversified testing service provider. The company provides testing services in the areas of minerals, life sciences, energy and industrial. It provides chemical and laboratory services, technical testing and inspection services supp …
  • Sahara Energy Ltd (SAH):石油・ガス:M&Aディール及び事業提携情報
    Summary Sahara Energy Ltd (Sahara Energy) is an oil and gas exploration and development company that acquires, exploits, explores, and develops oil and natural gas reserves in Western Canada. The company evaluates oil and gas exploration properties in Canada. It plans on growing through the drill bi …
  • Leap Therapeutics Inc (LPTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01, a humanized monoclonal antibody that targets the D …
  • Innovus Pharmaceuticals Inc (INNV):製薬・医療:M&Aディール及び事業提携情報
    Summary Innovus Pharmaceuticals Inc (Innovus Pharmaceuticals) is a pharmaceutical company that commercializes, licenses and develops over the counter and consumer healthcare products. The company’s products include non-drowsy allergy relief tablets, male fertility dietary supplements, blood sugar su …
  • Molecular Partners AG (MOLN):企業の財務・戦略的SWOT分析
    Summary Molecular Partners AG (Molecular Partners) is a clinical stage bio pharmaceutical company that develops biological drugs. The company offers advanced small protein therapies such as abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆